A Study of Imlifidase in Patients With Guillain-Barré Syndrome

Clinical trial NCT03943589 · COMPLETED

Trial details

NCT number: NCT03943589
Sponsor: Hansa Biopharma AB
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Guillain-Barré Syndrome (GBS)

Start date: 2019-11-12
Primary completion: 2024-02-27
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.